Related Experiment Video

Updated: Jun 1, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

[Adjuvant systemic treatment of melanoma]

K C Kähler1, F Egberts, A Hauschild

  • 1Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel. kckaehler@yahoo.de

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|June 10, 2011
PubMed

Insights

Stage IV melanoma remains fatal, with limited adjuvant treatment options. Interferon alfa (IFN-α) is the only approved adjuvant therapy, while new treatments like ipilimumab and MAGE-A3 peptide vaccination are under investigation.

Area of Science:

  • Oncology
  • Immunology
  • Dermatology

Context:

  • Stage IV melanoma has a poor prognosis despite extensive research.
  • Adjuvant therapy for high-risk melanoma patients is a critical unmet need.
  • Previous systemic adjuvant chemotherapy trials showed no survival benefit.

Purpose:

  • To review the current landscape of adjuvant therapy for stage IV melanoma.
  • To highlight the efficacy of Interferon alfa (IFN-α) as the sole approved adjuvant treatment.
  • To discuss emerging therapeutic strategies including novel compounds and vaccinations.

Summary:

  • Interferon alfa (IFN-α)-2a and -2b are the only approved adjuvant therapies for melanoma, demonstrating benefit in controlled studies.
  • Current research explores optimized Interferon schedules (pegylated vs. conventional) and novel agents.
  • Investigational treatments include the CTLA4 inhibitor ipilimumab and MAGE-A3 peptide vaccination.

Impact:

  • Identifies Interferon alfa as a current standard for adjuvant melanoma therapy.
  • Outlines promising future directions in melanoma treatment research.
  • Emphasizes the ongoing need for improved adjuvant therapies to reduce relapse and metastasis in stage IV melanoma.

More Related Videos

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...